Kubota, Y., Miyamoto, M., Takagi, G., Ikeda, T., Kirinoki-Ichikawa, S., Tanaka, K., & Mizuno, K. (2012). The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes. The Korean Academy of Medical Sciences.
Citação norma ChicagoKubota, Yoshiaki, Masaaki Miyamoto, Gen Takagi, Takeshi Ikeda, Sonoko Kirinoki-Ichikawa, Kotoko Tanaka, and Kyoichi Mizuno. The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes. The Korean Academy of Medical Sciences, 2012.
ציטוט MLAKubota, Yoshiaki, et al. The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes. The Korean Academy of Medical Sciences, 2012.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.